Related Experiment Video
Updated: Jan 28, 2026

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma
Published on: April 16, 2019
Ethical and Clinical Considerations in Treating Infections at the End of Life
Leigh Vaughan1, Ashley A Duckett, Mary Adler
1Leigh Vaughan, MD, FHM, FAAHPM, is assistant professor and fellowship director, Hospice and Palliative Medicine, Department on General Internal Medicine, Medical University of South Carolina, Charleston. Ashley A. Duckett, MD, FHM, is assistant professor and associate program director, Department of Internal Medicine, Medical University of South Carolina, Charleston. Mary Adler, ANP-C, ACHPN, is nurse practitioner, palliative care team, Medical University of South Carolina, Charleston. Joan Cain, FNP-BC, ACHPN, is nurse practitioner, palliative care team, Medical University of South Carolina, Charleston.
Abstract:
Patients often affirm the goal to pursue comfort at the end of life, although clinicians may struggle with how best to provide comfort and face the ethical dilemma of treating or allowing a suspected infection to unfold. Treating an infection at the end of life does not allow for uniform improvement in symptoms and more time with family and friends. Additionally, there is potential for burden to the patient or health care system and treatment may occur to the exclusion of other comfort measures. Currently, the practice of providing or forgoing antibiotics at the end of life is variable, and literature supporting best practices can be contradictory. Data to support the use or withholding of treatment have been scant and vary across settings and patient populations. We review common obstacles providers face, prognostication tools that may assist in clinical decision making, the ethical support for withholding therapy, and how to factor in potential burdens of treatment. We propose that nurses, whether at the bedside in an acute care or nursing facility or in the home setting as a member of the interdisciplinary home hospice team, are uniquely qualified to help patients and families navigate this challenging clinical decision.
More Related Videos
06:49Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians
Published on: March 14, 2014
06:51Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Published on: December 10, 2016
Related Concept Videos
Ethics in Research
Half-life of a Reaction
Endocarditis II: Clinical Features of Infective Endocarditis
Characteristics of Life
The Angiosperm Life Cycle
Design Consideration
The factor of safety is another key...